NeoTherma Oncology is answering the world’s call for more effective, more humane cancer treatment. NeoTherma Oncology is developing a groundbreaking type of radio frequency (RF) thermal treament for deep, solid tumors that is expected to increase the effectiveness of current cancer treatments, while minimizing the harshest effects of chemotherapy and radiation.
NeoTherma’s cutting edge non-invasive technology, seamless integration into established MRI treatment suites, and clinical development strategy set us apart as industry innovators with the vision to reimagine cancer treatment. Please see our website for more information and NTO's exciting news (http://neothermaoncology.com/)!
Company Details
- Employees
- 2
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://neothermaoncology.com
Neotherma Oncology Questions
Neotherma Oncology's website is http://neothermaoncology.com
Neotherma Oncology's LinkedIn profile is https://www.linkedin.com/company/neotherma-oncology
Neotherma Oncology has
2 employees.
View email and phone details for 2
employees at Neotherma Oncology.
Neotherma Oncology's industry is
Biotechnology Research
Neotherma Oncology's top competitors are
Love Lifesciences Inc.,
Bma Biomedicals,
Microfluidics Association,
Cellphmed,
New/era/mabs,
Microfluidic Valley,
Cis Pharma,
Afr Oncology,
Kanpecia Biotech Llc,
Phoreus Biotechnology, Inc..
Neotherma Oncology's categories are Biotechnology Research
